Importantly, similar results were obtained when the GSEA was restricted to MYC-translocation negative cases with >50% MYC-positive tumor nuclei by IHC (Figure 5B), providing molecular confirmation that the increased MYC protein expression detected in these cases correlates with the upregulation of MYC and MYC target genes. The gene discussed is MYC; the disease is neoplasm.